• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

International Isotopes begins thallium production

Article

Radiopharmaceutical manufacturer International Isotopes has begun producing thallium 201 at both its completed linear accelerator and its cyclotron facilities in Denton, TX. The firm expects that the production of thallium at both facilities will allow

Radiopharmaceutical manufacturer International Isotopes has begun producing thallium 201 at both its completed linear accelerator and its cyclotron facilities in Denton, TX. The firm expects that the production of thallium at both facilities will allow it to provide an ample supply of the isotope to hospitals and clinics in the U.S. Since it is situated near two airports, International Isotopes can ship isotopes with short half-lives overnight, according to Dr. Ira Lon Morgan, chairman and CEO. Thallium has a half-life of 73 hours and is used for the diagnosis of heart disease.

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.